Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus 131I-Tositumomab: Long-Term follow-up of phase III randomized study SWOG-S0016

Mazyar Shadman, Hongli Li, Lisa Rimsza, John P. Leonard, Mark S. Kaminski, Rita M. Braziel, Catherine M. Spier, Ajay K. Gopal, David G. Maloney, Bruce D. Cheson, Shaker Dakhil, Michael LeBlanc, Sonali M. Smith, Richard I. Fisher, Jonathan W. Friedberg, Oliver W. Press

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus 131I-Tositumomab: Long-Term follow-up of phase III randomized study SWOG-S0016'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology